Document:

exhibit102.htm

    

     

    

     

    

    Exhibit 10.2

    

    GLOBAL
HEADQUARTERS

    101 Gordon Drive ∙ Lionville,
PA 19341

    TEL 610-594-3327 ∙ FAX
610-594-3013

    rick.luzzi@westpharma.com

    RICHARD
D.
LUZZI                                                                

    Vice
President, Human Resources

    

    July 28,
2008

    

    

    

    Matthew
T. Mullarkey

    29844
Lake Road

    Bay
Village, OH 44140

    

    Re:           Your
2008 Plan Year and Performance Period VII Incentive Compensation

    

    Dear
Participant:

     

    Congratulations.  Effective
upon your commencement of employment, the Compensation Committee of our Board of
Directors granted you the following stock option and performance-vesting share
units.

    
      	
              Stock
      Option Award:

               

            	
              40,000

            
	
              Target
      PVS Units:

               

            	
              14,600

            

    

     

    The
awards were made under the terms of our 2007 Omnibus Incentive Compensation
Plan.  We have attached a summary of the terms of your
awards.  Please read it carefully.

     

    I am
pleased that you are a participant in this long-term incentive compensation
program and trust that your participation will be beneficial to both you and the
Company.

     

    Sincerely,

     

    /s/ Richard D.
Luzzi

     

    Enclosure

    

     

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

    

     

    
 

    
      Summary
of Your Stock Options

    

    

     

    What
is a stock option?

     

    A stock
option is the right to purchase a fixed number of shares at a set exercise
price.  The option granted by this award is a non-qualified stock
option.  The stock option gains value when the price of our common
stock exceeds the exercise price.

     

    How
many shares may I purchase and what is the price?

     

    The
number of shares you may purchase and the exercise price are as
follows:

    
      	
                     
      

              Exercise
      Price

            	
              Total
      shares that may be purchased 

                             
      upon exercise

            
	
              $
      45.27

            	
              40,000

            

    

    

    May
I purchase the shares immediately?

    No.  So
long as your employment with us continues, 25% of your option becomes
exercisable – or “vests” – each year for the first four years following the
grant date.  At the end of the four-year period, you may exercise the
entire option.  The following chart shows when and what portion of
your option becomes exercisable.

     

    
      	
               

              Date

            	
              Portion
      of the option

              that becomes
      exercisable

            
	
               

              July
      28 2008 (grant date)

            	
               

              0%

            
	
               

              February
      26, 2009

            	
               

              25%

            
	
               

              February
      26, 2010

            	
               

              50%

            
	
               

              February
      26, 2011

            	
               

              75%

            
	
               

              February
      26, 2012 and thereafter

            	
               

              100%

            

    

    

    However,
in no event will your option be exercisable after the Expiration
Date.

    When
will my option expire?

    The
option expires on February 26, 2018, which will be referred to as the
“Expiration Date.”  This means that once it becomes exercisable, the
option may be exercised until
February 25,
2018.  In
addition,

    
      	
              ·  

            	
              if
      you die, the option will remain exercisable for one year from your date of
      death;

            

    

     

    
      	
              ·  

            	
              if
      your employment terminates for any reason other than retirement,
      disability, death or removal for cause, the option will expire on 90 days
      after the termination date;

            

    

     

    
      	
              ·  

            	
              if
      we terminate your employment for cause, the option will expire on the
      commencement of business on your date of
  termination.

            

    

     

    How
do I exercise my stock option?

    There are
four ways to exercise a stock option.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    
      	
              ·  

            	
              Cash.  You
      write a check to the Company for the exercise price, plus any applicable
      withholding taxes.

            

    

     

    
      	
              ·  

            	
              Already owned
      shares.  You may deliver (or have the Company withhold)
      shares of common stock you own with a fair market value equal to the
      exercise price, plus any applicable withholding
  taxes.

            

    

     

    
      	
              ·  

            	
              Combination of shares and
      cash.  You may use a combination of cash and
      stock.

            

    

     

    
      	
              ·  

            	
              Reduction of
      proceeds.  With the consent of the Committee, you may
      elect to have shares you would otherwise receive upon the exercise reduced
      by an amount equal to the total exercise cost divided by the fair market
      value of the shares at the time of your exercise.  In effect,
      you would receive the “net” shares otherwise due you after deducting for
      the exercise cost, plus applicable withholding
  taxes.

            

    

     

    Enclosed
with this award is an Information Sheet about Computershare, the Company’s stock
plan administrator.  This contains important additional information
about how to exercise your Options.  Please review it
carefully.

    When
do I have to pay for the exercise?

    The full
exercise price and applicable taxes must be paid within three days of
exercise.

    Are
there any other restrictions on my ability to exercise my option?

    All
option exercise transactions by West’s officers who are subject to Section 16 of
the Securities and Exchange Act of 1934 must comply with the restrictions
contained in our Securities Trading Policy, including review by and written
pre-approval of our General Counsel.

    Are
there circumstances that would lead to a forfeiture of my award?

    Yes, in
certain situations you must give up amounts you receive as a result of the
option you exercise.  These situations are described
below.

    If within
(i) the term of the option or (ii) within 3 months following termination of
employment or (iii) within 3 months after you exercise any portion of the
option, whichever is the latest, you directly or indirectly engage in conduct
deemed to be any activity in competition with any activity of the Company, or
inimical, contrary or harmful to, or not in the best interests of, the Company
or if you fail to comply with any of the terms and conditions of the Plan or
this award (unless the failure is remedied within ten days after having been
notified of such failure), then any and all rights to exercise this option will
terminate and you must pay us an amount equal to any gain realized by you from
exercising all or any portion of this option.

    We may
also deduct from any amounts we owe you, such as amounts owed as wages or other
compensation, fringe benefits, or vacation paid.  Whether or not we
elect to make any deduction, if we do not recover the full amount you owe, you
agree to pay us immediately the unpaid balance.  By agreeing to accept
this award, you consent to our right to make these deductions.

    Are
there any other things I should be aware of?

    This is a
summary of the terms of your stock option award.  Your award is
subject to the terms of the 2007 Omnibus Incentive Compensation Plan. This award
is being delivered with an Information Statement, which gives additional
information about your award and the 2007 Omnibus Incentive Compensation Plan
under which it was granted.  We encourage you to read the Information
Statement.  Additional terms and conditions may apply to your award
under the terms of the Omnibus Plan.

    
      

      
        
          
          

        

        
          3

          
            

          

        

        
          
          

        

      

      Summary
of Your Performance-Vesting Share Unit Award

    

    

    What
is a performance-vesting share unit?

    A PVS
Unit award represents the conditional right to receive a distribution of
shares.  The number of shares you will receive depends on how well the
Company’s actual performance compares to specified performance goals at the end
of the performance period.

    What
are the performance goals?

    The
performance levels are based on two equally weighted performance
measures.  The two measures of Company performance are:

    
      	
              ·  

            	
              Average
      return on invested capital – also called “ROIC” – is measured by dividing
      the average of the Company’s net operating profit (without regard to
      taxes) over the performance period by the average outstanding equity plus
      debt over that period.

            

    

     

    
      	
              ·  

            	
              Compounded
      annual revenue growth – also called “CAGR” – is the compound annual growth
      rate in net sales for the Company over the same
  period.

            

    

     

    What
is the performance period?

    The
Company’s performance against the goals is measured over a three-year period
that begins January 1, 2008 and ends December 31, 2010 (“Performance Period
VII”).

    Your
target PVS Units award presented on the first page of this letter is the number of shares
of West Common Stock that you would receive if the Company obtains 100% of both
of the ROIC and CAGR performance targets.  Additional shares of Common
Stock will be distributable under this PVS award if actual performance exceeds
the target performance level, and fewer shares of Common Stock will be
distributable if actual performance falls short of the target performance
level.  No shares of Common Stock will be paid out if actual performance
falls below the minimum acceptable level.

    The
following table shows the performance targets for CAGR and Average ROIC and the
corresponding PVS Units payouts for Performance Period VII.

     

    
      	
               

            	
              CAGR

            	
              Average
    ROIC

            
	
               

            	
              (applies
      to 50% of PVS Units)

            	
              (applies
      to 50% of PVS Units)

            
	
              Performance
      Range

               

            	
              Performance

               

            	
              Payout

               

            	
              Performance

               

            	
              Payout

               

            
	
              Maximum:

               

            	
              150%

               

            	
              15%

               

            	
              200%

               

            	
              15%

               

            	
              200%

               

            
	
               

            	
              125%

               

            	
              12.5%

               

            	
              150%

               

            	
              12.5%

               

            	
              150%

               

            
	
               

               

            	
              110%

               

            	
              11%

               

            	
              120%

               

            	
              11%

               

            	
              120%

               

            
	
              Target:

               

            	
              100%

               

            	
              10%

               

            	
              100%

               

            	
              10%

               

            	
              100%

               

            
	
               

               

            	
              85%

               

            	
              8.5%

               

            	
              75%

               

            	
              8.5%

               

            	
              75%

               

            
	
              Threshold:

               

            	
              70%

               

            	
              7.0%

               

            	
              50%

               

            	
              7.0%

               

            	
              50%

               

            
	
              Less
      than 70%:

               

            	
              Less
      than 7.0%

               

            	
              -0-

               

            	
              Less
      than 70%

               

            	
              -0-

               

            

    

    

    If actual
CAGR or ROIC falls between any of the performance range percentages above, the
payout for that portion of your PVS Units will be determined by applying a
mathematical formula to estimate the value based on the two nearest
percentages.  For more information on the calculation, please see
below.

    Can
my award be changed?

    Yes, the
Committee can change or revise the targets as it considers
appropriate.  In the event of acquisitions or divestitures the
Committee will on a case-by-case basis determine the necessity to change or
revise the performance targets.

    When
will I know how many shares I am eligible to receive?

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    The
shares will be distributed to you in early 2011 after the ROIC and CAGR for the
performance period are calculated. This will be done by the Compensation
Committee after review of the Company’s audited financial
statements.

    Will
I receive dividends on my PVS Units?

    During
the Performance Period, your account will be credited with additional PVS Units
as if the target PVS Units award had been reinvested in dividends paid on Common
Stock during the period.  At the end of the Performance Period, you
may receive additional shares of Common Stock equal to the amount of PVS Units
credited through this dividend-reinvestment feature.  If performance
falls below the target levels, you may forfeit some or all of these PVS
Units.

    May
I defer receipt of my shares?

    Yes.  Delivery
of shares upon payout may be deferred under the Deferred Compensation Plan for
eligible participants in certain countries.  If you are eligible, you
will receive details on this deferral opportunity before the end of each
Performance Period.  You may similarly defer receipt of additional
shares you would otherwise receive due to the deemed dividend reinvestment
feature.

    Are
there circumstances under which my right to receive shares would
terminate?

    You will
not be entitled to receive a distribution with respect to any PVS Units granted
by this award if:

     

    
      	
              1.  

            	
              Your
      employment terminates for any reason before the end of Performance Period;
      or

            

    

     

    
      	
              2.  

            	
              If
      at any time during your employment or within 3 months following
      termination of your employment, you directly or indirectly engage in
      activity harmful to, or not in the best interest of, the
      Company.  Such activity includes, without
      limitation:

            

    

     

    
      	
              ·  

            	
              conduct
      related to your employment for which either criminal or civil penalties
      against you may be sought;

            

    

     

    
      	
              ·  

            	
              acquisition
      of a direct or indirect interest or an option to acquire such an interest
      in any person or entity engaged in competition with the Company’s business
      (other than an interest of not more than 5 percent of the outstanding
      stock of any publicly traded
company);

            

    

     

    
      	
              ·  

            	
              accepting
      employment with or serving as a director, officer, employee or consultant
      of, or furnishing information to, or otherwise facilitating the efforts
      of, any person or entity engaged in competition with the Company’s
      business;

            

    

     

    
      	
              ·  

            	
              soliciting,
      employing, interfering with, or attempting to entice away from the Company
      any employee who has been employed by the Company in an executive or
      supervisory capacity within one year before such solicitation, employment,
      interference or enticement;

            

    

     

    
      	
              ·  

            	
              violation
      of Company policies, including the Company’s insider-trading policy;
      or

            

    

     

    
      	
              ·  

            	
              using
      for yourself or others, or disclosing to others, any confidential or
      proprietary information of the Company in contravention of any Company
      policy or agreement.

               

            

    

    Are
there any other things I should be aware of?

     

    This is
summary of your PVS Unit award.  Your award is subject to the terms of
the 2007 Omnibus Incentive Compensation Plan.   This award is
being delivered with an Information Statement, which gives additional
information about your award and the 2007 Omnibus Incentive Compensation Plan
under which it is granted.  We encourage you to read the Information
Statement.  Additional terms and conditions may apply to your award
under the terms of the Plan

    
      
         

      

      
        5exhibit103.htm

    

    Exhibit
10.3

                                             GLOBAL
HEADQUARTERS

    101 Gordon Drive ∙ Lionville,
PA 19341

    TEL 610-594-3327 ∙ FAX
610-594-3013

    rick.luzzi@westpharma.com

    RICHARD
D.
LUZZI                                                                

    Vice
President, Human Resources

    

    

    

    

    July 28, 2008

    

    

    

    Mr.
Matthew T. Mullarkey

    29844
Lake Road

    Bay
Village, OH 44140

    

    Re:           Severance and
Non-Competition Agreement

    

    Dear
Matt:

     

    In
consideration of your employment with West Pharmaceutical Services, Inc. (the
“Company”) as its Chief Operating Officer, you and the Company, intending to be
legally bound, agree as follows:

     

    
      	
              1.  

            	
              Termination
      of Employment.
      You will be entitled to the benefits specified in Section 2 if your
      employment with the Company is terminated by the Company, other than for
      cause or by reason of death, disability, or retirement at normal or early
      retirement age pursuant to the Company’s Employees’ Retirement Plan (or
      any successor pension plan thereto) (the “Retirement Plan”) or if you have
      a Constructive Termination (as defined in the Change in Control Agreement
      between you and the Company, dated July 28, 2008 (the “CIC
      Agreement”).  You will not be entitled to the benefits
      specified in Section 2 if your employment terminates for any other
      reasons, including, without limitation, your voluntary resignation, or if,
      during the term of your employment or at any time thereafter, you engage
      in any activity specified in Section 3
hereof.

            

    

     

    
      	
              a)  

            	
              Constructive
      Termination.  If you terminate your employment due to a
      Constructive Termination, you must satisfy each of the conditions
      contained in the CIC Agreement and you must notify the Company of the
      circumstances giving rise to a Constructive Termination within 10 days of
      the date you knew or should have known that those circumstances
      existed.

            

    

     

    
      	
              b)  

            	
              Release.  Any
      benefits payable hereunder are conditioned upon your execution,
      non-revocation and compliance with the terms of a Release substantially in
      the form attached hereto as Exhibit
      A.

            

    

     

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

    

     

    
      	
              2.  

            	
              Benefits
      Payable Upon Termination of Employment.
      Upon termination of employment as set forth in Section 1, you shall
      be entitled to the following
benefits:

            

    

     

    
      	
            	
              a)  

            	
              Severance
      Compensation. Your regular salary as in effect on the date of
      termination of your employment will continue for a period of twelve
      months, with normal deductions. The salary continuation payments shall be
      made on the Company’s normal payroll cycle.  Notwithstanding
      anything herein to the contrary, to the extent that you are a “specified
      employee” and payments must be delayed six months as required by section
      409A(a)(2)(B) of the Internal Revenue Code of 1986, the first six months
      of payments required to be paid under this Agreement shall be made on the
      first normal payroll date that is six months following your termination of
      employment in a single, lump sum and each subsequent payment shall be made
      on the normal payroll date.  The severance compensation paid
      hereunder shall not be reduced to the extent of any other compensation for
      your services which you receive or are entitled to receive from any other
      employment consistent with the terms of this
  Agreement.

            

    

     

    
      	
            	
              b)  

            	
              Employee
      Benefits. You shall be entitled to a continuation of all medical,
      dental and life insurance in the same manner and amount to which you were
      entitled on the date of termination of your employment until the earlier
      of (i) a period of twelve months after termination of your employment, or
      (ii) your eligibility for similar benefits with a new employer. All other
      benefits not otherwise addressed in this Agreement shall terminate as of
      the date of termination of your
employment.

            

    

     

    
      	
              3.  

            	
              Termination
      of Benefit.
      The Company shall have no obligation to provide or continue any of
      the benefits under Section 2 (except as required by applicable law) upon
      the breach of any of your obligations (i) under Section 4 hereof, (ii) the
      provisions of your Confidentiality Agreement with the Company, which is
      attached to your Change-in-Control Agreement with the Company as Exhibit A
      and incorporated by reference herein, or (iii)
  you:

            

    

     

    
      	
            	
              a)  

            	
              engage
      in conduct in connection with your employment for which criminal or civil
      penalties against you or the Company may be sought;
  and

            

    

     

    
      	
            	
              b)  

            	
              violate
      any of the Company’s material policies, including without limitation the
      Company’s insider-trading policy.

            

    

     

    
      	
              4.  

            	
              Covenant Not To
      Compete.

            

    

     

    
      	
               
      

            	
              a)

            	
              During
      the period beginning on the date of your termination of employment and
      ending on the first anniversary thereof (the “Restrictive Period”), you
      will not, and will not permit any of your Affiliates, or any other Person,
      directly or indirectly, to:

            

    

     

    
      	
              i)  

            	
              engage
      in competition with, or acquire a direct or indirect interest or an option
      to acquire such an interest in any Person engaged in competition with, the
      Company’s Business in the United States (other than an interest of not
      more than 5 percent of the outstanding stock of any publicly traded
      company);

            

    

     

    
      	
              ii)  

            	
              serve
      as a director, officer, employee or consultant of, or furnish information
      to, or otherwise facilitate the efforts of, any Person engaged in
      competition with the Company’s Business in the United
    States;

            

    

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    
      	
              iii)  

            	
              solicit,
      employ, interfere with or attempt to entice away from the Company any
      employee who has been employed by the Company or a Subsidiary in an
      executive or supervisory capacity in connection with the conduct of the
      Company’s Business within one year prior to such solicitation, employment,
      interference or enticement; or

            

    

     

    
      	
              iv)  

            	
              approach,
      solicit or deal with in competition with the Company or any Subsidiary any
      Person which at any time during the 12 months immediately preceding the
      Termination Date:

            

    

     

    
      	
              (1)  

            	
              was
      a customer, client, supplier, agent or distributor of the Company or any
      Subsidiary;

            

    

     

    
      	
              (2)  

            	
              was
      a customer, client, supplier, agent or distributor of the Company or any
      Subsidiary with whom employees reporting to or under your direct control
      had personal contact on behalf of the Company or any Subsidiary;
      or

            

    

     

    
      	
              (3)  

            	
              was
      a Person with whom you had regular, substantial or a series of business
      dealings on behalf of the Company or any Subsidiary (whether or not a
      customer, client, supplier, agent or distributor of the Company or any
      Subsidiary).

            

    

    

    
      	
              b)  

            	
                 As
      used in this Section, each of the capitalized terms that are not
      separately defined herein shall have the same meaning contained in the CIC
      Agreement.  For the avoidance of doubt, you agree that the
      phrase “Person engaged in competition with the Company’s Business” as used
      in this Section includes, the companies listed on Exhibit B to your CIC
      Agreement, and their Affiliates and
  Subsidiaries.

            

    

     

    
      	
              5.  

            	
              Payments
      Final and Exclusive. In
      the event of a termination of your employment under the circumstances
      described in this Agreement, the arrangements provided for by this
      Agreement, or any other agreement between the Company and you in effect at
      that time and by any other applicable plan of the Company in which you
      then participate shall constitute the entire obligation of the Company to
      you, and performance of that obligation shall constitute the settlement of
      any claim that you might otherwise assert against the Company on account
      of such termination.  You agree that if you are entitled to
      payments or benefits under this Agreement, that you will not separately be
      entitled to any severance under any applicable plan, agreement or policy
      of the Company, nor will you be entitled to receive any of the benefits
      under your CIC Agreement.  Furthermore, you agree that if you
      are entitled to receive payments or benefits under your CIC Agreement, you
      will not separately be entitled to receive any payments or benefits under
      this Agreement.

            

    

     

    
      	
              6.  

            	
              Duration
      of Agreement;
      Amendment.
      This Agreement may not be terminated or amended by either party,
      except that this Agreement may be terminated or amended at any time by the
      mutual written consent of you and the
Company.

            

    

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    
      	
              7.  

            	
              Enforcement.
      You acknowledge that a breach of this Agreement will cause the
      Company immediate and irreparable harm for which the Company’s remedies at
      law (such as money damages) will be inadequate. The Company shall have the
      right, in addition to any other rights it may have, to obtain an
      injunction to restrain any breach or threatened breach of this Agreement.
      Should any provision of this Agreement be adjudged to any extent invalid
      by any competent tribunal, that provision will be deemed modified to the
      extent necessary to make it enforceable. The Company may contact any
      Person with or for whom you work after your employment by the Company ends
      and may send that Person a copy of this
  Agreement.

            

    

     

    
      	
              8.  

            	
              Miscellaneous.

            

    

     

    
      	
              a)  

            	
              This
      Agreement will be binding upon and inure to the your benefit, your
      personal representatives and heirs and the Company and any successor of
      the Company, but neither this Agreement nor any rights arising hereunder
      may be assigned or pledged by you.

            

    

     

    
      	
              b)  

            	
              You
      acknowledge that a breach of the covenants contained in this Agreement
      will cause the Company immediate and irreparable harm for which the
      Company’s remedies at law (such as money damages) will be inadequate. The
      Company shall have the right, in addition to any other rights it may have,
      to obtain an injunction to restrain any breach or threatened breach of
      such Sections. The Company may contact any Person with or for whom you
      work after your employment by the Company ends and may send that Person a
      copy of this Agreement.

            

    

     

    
      	
              c)  

            	
              Should
      any provision of this Agreement be adjudged to any extent invalid by any
      competent tribunal, that provision will be deemed modified to the extent
      necessary to make it enforceable.  The invalidity or
      unenforceability of any provision hereof or Exhibit hereto shall in no way
      affect the validity or enforceability of any other provision
      hereof.

            

    

     

    
      	
              d)  

            	
              This
      Agreement will be governed and construed in accordance with the laws of
      the Commonwealth of Pennsylvania.

            

    

     

    
      	
              e)  

            	
              This
      Agreement constitutes the entire agreement and understanding between the
      Company and you with respect to the subject matter hereof and merges and
      supersedes all prior discussions, agreements and understandings between
      the Company and you with respect to such
  matters.

            

    

     

    
      	
              f)  

            	
              This
      Agreement may be executed in one or more counterparts, which together
      shall constitute a single
agreement.

            

    

     

    If you
are in agreement with the foregoing, please so indicate by signing and returning
to the Company the enclosed copy of this letter, whereupon this letter shall
constitute a binding agreement between you and the Company and our mutual
intention to be legally bound as of the date and year first written
above.

     

     

    Very
truly yours,

    

    WEST
PHARMACEUTICAL SERVICES, INC.

    

    

       By:
/s/ Richard D.
Luzzi                                                                           

    Richard D. Luzzi

    Vice President, Human
Resources

    

    

    

    Accepted
and Agreed To:

    

     

    /s/ M
Mullarkey                                                

    Matthew
T. Mullarkey

     

    

    
      
        
           

        

        
          4

          
            

          

        

        
           

        

      

    

    

    EXHIBIT
A

    

    AGREEMENT AND GENERAL
RELEASE

     

    
      	
              NOTICE:  This is a very important
      legal document, and you should thoroughly review and understand the terms
      and effect of this document before signing it.  By signing this
      Agreement and General Release, you will be completely releasing West
      Pharmaceutical Services, Inc. from all liability to
      you.  Therefore, you should consult with an attorney before
      signing this Agreement and General Release.  You have twenty-one (21) days
      from the date of distribution of these materials to consider this
      document.  If you have not returned a signed copy of this
      Agreement and General Release by that time, we will assume that you have
      elected not to sign the Agreement and General Release.  If you
      choose to sign the Agreement and General Release, you will have an additional seven (7)
      days following the date of your signature to revoke the Agreement
      and General Release, and the Agreement and General Release between you and
      the Company shall become effective or enforceable until the revocation
      period has expired.  Any revocation of this
      Agreement and General Release must be in writing and must be personally
      delivered or mailed to Richard D. Luzzi, Vice President, Human
      Resources.

            

    

    

    Intending
to be legally bound by the provisions of this Agreement and in consideration of
the negotiated payments and benefits specified in the Letter Agreement to which
this Agreement and General Release is attached as Exhibit A, which shall be
incorporated as if fully set forth within, dated ___________, between West
Pharmaceutical Services, Inc. and me, providing valuable consideration to which
I would otherwise not be entitled, I, Matthew T. Mullarkey, hereby release and
discharge West Pharmaceutical Services, Inc. and its affiliates, parents,
subsidiaries, successors, and predecessors and all of their employees, agents,
attorneys, officers, and directors (individually and collectively referred to as
the “Company”) from any and all claims and/or causes of action, whether known to you or the Company
at the time of the execution of this General Release or not, which I may
have or could claim to have against the Company in connection with my employment
with the Company up to and including the date of my signing of this General
Release.

     

    This
General Release includes, but is not limited to, a full waiver of all claims
arising from or during my employment or as a result of the termination of my
employment and all claims arising under federal, state, or local laws
prohibiting employment discrimination based upon age, race, sex, religion,
handicap, national origin, or any other protected characteristic, including, but
not limited to, any and all claims arising under the Age Discrimination in
Employment Act (“ADEA”), Title VII of the Civil Rights Act of 1964 and
1991, the Americans with Disabilities Act, the Family and Medical Leave Act, the
Equal Pay Act, the Pennsylvania Wage Payment and Collection Law, the
Pennsylvania Human Relations Act, any other federal, state or local labor or
employment law, and claims under the common law and/or growing out of any legal
restrictions, express or implied, in contract or on any other grounds, or the
Company’s right to control or terminate the employment of its
employees.

     

    By
signing below, I acknowledge that I have carefully read and fully understand the
provisions of this Agreement and General Release.  I further
acknowledge that I am signing this Agreement and General Release knowingly and
voluntarily and without duress, coercion or undue influence.  I agree
that I will not file a lawsuit asserting any claims barred by this General
Release against the Company.  If I breach this promise, then I will
reimburse the Company for its reasonable attorneys’ fees and costs incurred in
defending against such released Claims, and I shall also be obligated to tender
back upon filing of such complaint in state or federal court or before any
administrative agency any consideration that I have received pursuant to the
severance arrangements provided within the accompanying Letter
Agreement.  A suit challenging the validity of this General Release
under ADEA, however, shall not be subject to the provisions of this
paragraph.

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    I agree
that this Agreement and General Release may be pleaded as a complete bar to any
action or suit before any court, arbitral or administrative body with respect to
any of the released claims.

     

    This
Agreement and General Release together with the Letter Agreement constitutes the
total and complete understanding between me and the Company relating to the
subject matter covered by this Agreement and General Release and all other prior
or contemporaneous written oral agreements or representations, except the
accompanying Letter Agreement setting forth the terms of my severance
arrangement, if any, otherwise relating to the subject matter of this Agreement
and General Release are null and void.  It is also expressly
understood and agreed that the terms of this Agreement and General Release may
not be altered except in writing signed by both the Company and me.  I
further understand and agree that the terms and conditions of this Agreement and
General Release shall not be communicated to any persons other than those
referred to herein and to my spouse or legal counsel, if
applicable.  Finally, it is understood and agreed that the execution
of this Agreement and General Release is not an admission of liability on the
part of either party.

     

    This
Agreement and General Release shall be governed in all respects, whether as to
validity, construction, capacity, performance, or otherwise, by the laws of the
Commonwealth of Pennsylvania, and no action involving this Agreement may be
brought except in the state courts located in Chester County, Pennsylvania or
the Federal District Court for the Eastern District of
Pennsylvania.

    

    If any
provision of this Severance Agreement and General Release, or the application
thereof, is held to be invalid, void or unenforceable for whatever reason, the
remaining provisions not so declared shall nevertheless continue in full force
and effect without being impaired in any manner whatsoever.   If
any party waives any provision of this Agreement, such waiver shall not affect
any provision of the agreement not specifically waived.

    

     

    INTENDING
TO BE LEGALLY BOUND, I hereby set my hand and seal below:

     

    Witnessed
by:                                                                                             EMPLOYEE

    

    

    ______________________________                                                                                     ____________________________

                                                       Matthew T.
Mullarkey

    

    DATED                                                                                                 DATED

    

    

    ______________________________                                                                                     _____________________________

    

    

    
      
        
          
             

          

           

        

        
          6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}]]